Efficacy of Once-Daily Olopatadine 0.2% Ophthalmic Solution Compared to Twice-Daily Olopatadine 0.1% Ophthalmic Solution for the Treatment of Ocular Itching Induced by Conjunctival Allergen Challenge

Mark B. Abelson; Dennis L. Spangler; Arthur B. Epstein; Francis S. Mah; H. Jerome Crampton

doi:10.1080/02713680701736558

Efficacy of Once-Daily Olopatadine 0.2% Ophthalmic Solution Compared to Twice-Daily Olopatadine 0.1% Ophthalmic Solution for the Treatment of Ocular Itching Induced by Conjunctival Allergen Challenge

Current Eye Research ◽

10.1080/02713680701736558 ◽

2007 ◽

Vol 32 (12) ◽

pp. 1017-1022 ◽

Cited By ~ 11

Author(s):

Mark B. Abelson ◽

Dennis L. Spangler ◽

Arthur B. Epstein ◽

Francis S. Mah ◽

H. Jerome Crampton

Keyword(s):

Allergen Challenge ◽

Ophthalmic Solution ◽

Once Daily ◽

Ocular Itching ◽

Conjunctival Allergen Challenge

Download Full-text

Phase 3 Randomized Double-Masked Study of Efficacy and Safety of Once-Daily 0.77% Olopatadine Hydrochloride Ophthalmic Solution in Subjects With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge Model

Cornea ◽

10.1097/ico.0000000000000562 ◽

2015 ◽

Vol 34 (10) ◽

pp. 1245-1251 ◽

Cited By ~ 7

Author(s):

Eugene McLaurin ◽

Abhijit Narvekar ◽

Paul Gomes ◽

Adeniyi Adewale ◽

Gail Torkildsen

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Efficacy And Safety ◽

Phase 3 ◽

Once Daily ◽

Conjunctival Allergen Challenge ◽

Olopatadine Hydrochloride

Download Full-text

Bepotastine Besilate Ophthalmic Solution 1.5% Produces Strong Clinical Benefit for Ocular Itching Immediately Following Dosing in the Conjunctival Allergen Challenge (CAC) Model of Allergic Conjunctivitis

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2010.12.1021 ◽

2011 ◽

Vol 127 (2) ◽

pp. AB256-AB256

Author(s):

J.C. Clark ◽

J.I. Williams ◽

P.J. Gomes ◽

M.B. Abelson ◽

J.A. Gow ◽

...

Keyword(s):

Clinical Benefit ◽

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Ocular Itching ◽

Conjunctival Allergen Challenge

Download Full-text

Efficacy of Ketotifen Fumarate 0.025% Ophthalmic Solution Compared With Placebo in the Conjunctival Allergen Challenge Model

Archives of Ophthalmology ◽

10.1001/archopht.121.5.626 ◽

2003 ◽

Vol 121 (5) ◽

pp. 626 ◽

Cited By ~ 17

Author(s):

Mark B. Abelson

Keyword(s):

Allergen Challenge ◽

Ophthalmic Solution ◽

Ketotifen Fumarate ◽

Conjunctival Allergen Challenge

Download Full-text

Evaluation of olopatadine 0.2% in the complete prevention of ocular itching in the conjunctival allergen challenge model

Clinical Optometry ◽

10.2147/opto.s21181 ◽

2011 ◽

pp. 57 ◽

Cited By ~ 1

Author(s):

Maria Tort ◽

Alan Kabat ◽

Amin ◽

Blaiss ◽

Maria Tort

Keyword(s):

Allergen Challenge ◽

Ocular Itching ◽

Conjunctival Allergen Challenge

Download Full-text

Emedastine ophthalmic solution 0.05% versus levocabastine ophthalmic suspension 0.05% in the treatment of allergic conjunctivitis using the conjunctival allergen challenge model

American Journal of Ophthalmology ◽

10.1016/s0002-9394(00)00689-9 ◽

2000 ◽

Vol 130 (6) ◽

pp. 717-723 ◽

Cited By ~ 18

Author(s):

Peter A Netland ◽

Charles Leahy ◽

Kathleen L Krenzer

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Conjunctival Allergen Challenge ◽

Ophthalmic Suspension

Download Full-text

Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial

Clinical Therapeutics ◽

10.1016/s0149-2918(03)80199-6 ◽

2003 ◽

Vol 25 (7) ◽

pp. 1975-1987 ◽

Cited By ~ 28

Author(s):

H.Jerome Crampton

Keyword(s):

Controlled Trial ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Signs And Symptoms ◽

Allergic Rhinoconjunctivitis ◽

Ketotifen Fumarate ◽

Conjunctival Allergen Challenge

Download Full-text

Bioequivalence of two formulations of ketotifen fumarate ophthalmic solution: A single-center, randomized, double-masked conjunctival allergen challenge investigation in allergic conjunctivitis

Clinical Therapeutics ◽

10.1016/s0149-2918(08)80051-3 ◽

2008 ◽

Vol 30 (7) ◽

pp. 1272-1282 ◽

Cited By ~ 10

Author(s):

Gail L. Torkildsen ◽

Mark B. Abelson ◽

Paul J. Gomes

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Single Center ◽

Ketotifen Fumarate ◽

Conjunctival Allergen Challenge

Download Full-text

A randomized, double-blind, placebo-controlled comparison of emedastine 0.05% ophthalmic solution with loratadine 10 mg and their combination in the human conjunctival allergen challenge model

Clinical Therapeutics ◽

10.1016/s0149-2918(02)85045-7 ◽

2002 ◽

Vol 24 (3) ◽

pp. 445-456 ◽

Cited By ~ 17

Author(s):

Mark B. Abelson ◽

Allen P. Kaplan

Keyword(s):

Allergen Challenge ◽

Ophthalmic Solution ◽

Double Blind ◽

Double Blind Placebo ◽

Conjunctival Allergen Challenge

Download Full-text

Comparison of the clinical efficacy and comfort of olopatadine hydrochloride 0.1% ophthalmic solution and nedocromil sodium 2% ophthalmic solution in the human conjunctival allergen challenge model

Clinical Therapeutics ◽

10.1016/s0149-2918(00)83044-1 ◽

2000 ◽

Vol 22 (12) ◽

pp. 1462-1472 ◽

Cited By ~ 36

Author(s):

Salim Butrus ◽

Jack V. Greiner ◽

Marino Discepola ◽

Ira Finegold

Keyword(s):

Clinical Efficacy ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Nedocromil Sodium ◽

Conjunctival Allergen Challenge ◽

Olopatadine Hydrochloride

Download Full-text

364 Zero Itch in Eyes Treated With Olopatadine Hydrochloride Ophthalmic Solution, 0.2% in Bilateral Conjunctival Allergen Challenge Studies

World Allergy Organization Journal ◽

10.1097/01.wox.0000412127.79639.64 ◽

2012 ◽

Vol 5 ◽

pp. S116-S117

Author(s):

Michael S. Blaiss ◽

Maria Tort

Keyword(s):

Allergen Challenge ◽

Ophthalmic Solution ◽

Conjunctival Allergen Challenge ◽

Olopatadine Hydrochloride

Download Full-text